International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and … – Markets Insider
|
International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and …
Markets Insider “ISCO was one of the first stem cell biotech companies to build a business model in which revenue-generating subsidiaries operate under a parent R&D company. This not only decreases cash burn while conducting our Parkinson's disease clinical trial, but … |
